Drug-eluting live tissue for transplantation
US10814036B2 · kind B2 · utility
0Cited by
7References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 7, 2017 |
| Grant date | Oct 27, 2020 |
| Priority date | — |
| Expiry date | Nov 7, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2400/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for the ex vivo modification of the surfaces of viable tissue result in tissue modifications that are stable and/or result in the controlled release of active compounds, and are expected to provide effective protection for transplanted tissue subsequent to transplant.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.